|
JP2020019757A
|
|
Palonosetron-containing liquid composition
|
|
JP2019202981A
|
|
Levocetirizine solid preparation
|
|
JP2019059710A
|
|
Levocetirizine solid preparation
|
|
JP2018203706A
|
|
Tablet containing blonanserin
|
|
JP2018203705A
|
|
Levocetirizine solid preparation
|
|
JP2018184382A
|
|
Ezetimibe-containing tablet and method for producing the same
|
|
JP2018184381A
|
|
Ezetimibe-containing tablet and method for producing the same
|
|
JP2018020999A
|
|
Atomoxetine tablet and method for producing atomoxetine tablet
|
|
JP2018020998A
|
|
Atomoxetine tablet and method for producing atomoxetine tablet
|
|
JP2017002030A
|
|
Liquid agent for internal use containing aripiprazole
|
|
JP2017206488A
|
|
Gefitinib tablet and method for producing gefitinib tablet
|
|
JP2017052743A
|
|
Montelukast pharmaceutical formulation
|
|
JP2017002022A
|
|
Voriconazole-containing preparation
|
|
JP2016204347A
|
|
Montelukast sodium granular preparation
|
|
JP2016204346A
|
|
Aripiprazole pharmaceutical preparation
|
|
JP2015040206A
|
|
Oral fast-disintegrating tablet containing irritative (astringency, acidity, bitterness) drug and method for producing the same
|
|
JP2014028804A
|
|
Fexofenadine granule formulation and manufacturing method of the same
|
|
JP2014234385A
|
|
Clopidogrel-containing tablet and method for producing the same
|
|
JP2014159393A
|
|
Cetirizine granular preparations
|
|
JP2014124329A
|
|
Exterior bag for storing infusion solution bag, and infusion solution bag unit
|
